Navigation Links
Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
Date:4/30/2008

ity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of Pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, Cytogenetics automated systems, and Transgenomic Pharmacogenomics and Reference Laboratory Services. Transgenomic Pharmacogenomics and Laboratory Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: http://www.transgenomic.com.

Transgenomic Cautionary Statements

Certain statements in this press release constitute "forward-looking statements" of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic's reports to the Securities and Exchange Commission. Any change in such factors, r
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
4. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
5. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... ENDO 2013, the Endocrine Society,s 95 th ... both melatonin and cortisol rhythms. This effect further ... clock and address the circadian desynchrony which is ... and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study ...
(Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...
(Date:6/17/2013)... June 17, 2013 The following is a Statement ... at Drugfree.org :   Last Friday, ... was halting the sale of prescription drug paraphernalia products. The ... that from time to time there may be individual items ... As a result of this misinterpretation we are electing to ...
Breaking Medicine Technology:Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4A Win for Families: Urban Outfitters Halts Prescription Drug Paraphernalia Product Sales 2
... it has been selected as a Finalist ... list honoring the year,s most promising private technology ventures ... The Red Herring editorial team selected the most innovative ... America. The nominees are evaluated on both quantitative and ...
... a full-service pharmacy benefit management and ancillary medical ... Craig Rollins has joined the organization as Vice ... role he will be responsible for the strategic ... 1Click Ancillary online marketplace. myMatrixx launched 1Click Ancillary ...
Cached Medicine Technology:DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award 2myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development 2
(Date:6/17/2013)... NY (PRWEB) June 17, 2013 The Woodstock ... Blake to attend the Festival this summer, which will be ... through Sunday, August 25th. , Blake professes the benefits ... a day to fuel his world class sprinting abilities. ... volume of fruit is drawing attention. "Yohan Blake believes in ...
(Date:6/17/2013)... City Beach, FL (PRWEB) June 17, 2013 ... higher purpose--fighting hunger. Oceana Naturals LLC, the US distributor ... region of The Bay Area Food Bank ... families, and struggling seniors by seeing that they receive ... Natural Sunscreen and All Natural Moisturizer. Contributions will ...
(Date:6/17/2013)... (June 17, 2013) A team from the New ... Naomi Berrie Diabetes Center of Columbia University has generated ... the features of maturity-onset diabetes of the young (MODY). ... patients to produce induced pluripotent stem (iPS) cells, from ... mouse, the stem cell-derived beta cells secreted insulin in ...
(Date:6/17/2013)... Keller, TX (PRWEB) June 17, 2013 Tarrant ... special. , The term ‘mommy makeover’ has recently undergone ... from surgeon to surgeon. At Tarrant Plastic Surgery, they regard ... procedures designed to remove and reverse many of the effects ... the breast may typically include: drooping of the breast with ...
(Date:6/17/2013)... new drug called pyrvinium pamoate inhibits aggressive forms of ... to a study conducted in an animal model. The ... 95th Annual Meeting in San Francisco. , "Our novel ... action," said study lead author Jeremy Jones, PhD, assistant ... Research Institute, in Duarte, CA. "Thus, it has the ...
Breaking Medicine News(10 mins):Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2Health News:New medication treats drug-resistant prostate cancer in the laboratory 2
... Delhi is planning to interlink its major 29 hospitals ... and treatment provided. This computerization and interlinking of data ... by which doctors can know the case history and ... modules of software to deal with different hospital departments. ...
... number of psychiatric disorders, including mood disorders, schizophrenia// ... shown to increase the risk for emergence of ... disorder), and that presence of certain anxiety disorders ... development of nicotine dependence. ,A recent study ...
... or growing fast: systematic review of size and growth ... who grow rapidly during the first two years of life, ... a study reveals. ,There is an urgent need to ... is not clear how early in life prevention could begin. ...
... is no link whatsoever between breast cancer and cholesterol levels ... control the same. ,The details of the study ... Internal Medicine, one of the JAMA/Archives journals. The article says ... to suggest that the statins may work in conjunction with ...
... compulsory licensing (CL) provision in the Patents Act that ... Swiss drug maker Roche’s patented drug Tamiflu, useful in ... flu virus. , ,Section 92 empowers the government ... the industry. Furthermore, the issue of such license is ...
... a large, heterogeneous group of rare pulmonary disorders ... abnormal gas exchange with considerable mortality and morbidity. ... diagnosis includes more than 100 conditions in both ... and Colorado conducted a descriptive, observational study was ...
Cached Medicine News:Health News:Delhi Government To Interlink All Major Hospitals Through e-Governance 2Health News:Smokers Are Prone To Number Of Psychiatric Disorders 2Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2
Full Handle Laseredge Implant Blade Knife, 5.2 mm straight. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, angled double bevel. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Crescent Blade Knife, angled bevel up. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: